April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Restoring Light Sensitivity in Blind Mouse Retinas With an AAQ Photoswitch Molecule
Author Affiliations & Notes
  • A. Polosukhina
    Vision Science,
    U C Berkeley, Berkeley, California
  • T. Huang
    Vision Science,
    U C Berkeley, Berkeley, California
  • I. Tochitsky
    Vision Science,
    U C Berkeley, Berkeley, California
  • Y. Sychev
    Ophthalmology, University of Washington, Seattle, Washington
  • D. Trauner
    Chemistry and Biochemistry, Ludwig-Maximilians-Universität München (LMU), Berkeley, Germany
  • R. Van Gelder
    Ophthalmology, University of Washington, Seattle, Washington
  • R. Kramer
    Vision Science, Molecular Biology,
    U C Berkeley, Berkeley, California
  • Footnotes
    Commercial Relationships  A. Polosukhina, None; T. Huang, None; I. Tochitsky, None; Y. Sychev, None; D. Trauner, None; R. Van Gelder, None; R. Kramer, None.
  • Footnotes
    Support  NEI grant EY018957 to RHK; Nanomedicine Center (PN2 EY018241).
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3469. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Polosukhina, T. Huang, I. Tochitsky, Y. Sychev, D. Trauner, R. Van Gelder, R. Kramer; Restoring Light Sensitivity in Blind Mouse Retinas With an AAQ Photoswitch Molecule. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3469.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Retinitis pigmentosa (RP) is an inherited neurological disease that leads to blindness due to the progressive loss of rod and cone photoreceptors. We have developed a photochemical approach that ultimately might provide a treatment for RP and other retinal degenerative diseases. We are using acrylamide-azobenzene-quaternary-ammonium (AAQ), a photoisomerizable molecule that bestows light sensitivity onto endogenous voltage-gated K+ (Kv) channels. We evaluated whether AAQ could restore light sensitivity to retinas from mice with mutations that lead to blindness.

Methods: : We applied AAQ (300 uM) onto flat-mount retinas from 6 month rd1 mice. After 25 minute treatment, AAQ was washed away. We performed electrophysiological recordings before and after a 25 minute treatment with AAQ. We used the whole-cell patch clamp method to evaluate ionic currents regulated by light in single retinal ganglion cells (RGCs) and a multielectrode array (MEA) to record from populations of RGCs. To investigate behavioral restoration of light sensitivity, we injected AAQ into the vitreous, and measured the pupillary reflex in the triple knockout mice (tra-/-,cnga3-/-,opn4-/- ) which normally fail to generate the reflex.

Results: : MEA recordings showed that retinas not treated with AAQ did not show light responses. However, after the AAQ treatment, consistently robust light responses were recorded from populations of RGCs. Whole-cell recordings from AAQ treated retinal ganglion cells (RGCs) show that we can directly control Kv currents with light. In addition to regulating intrinsic conductances, we have found that light regulates inhibitory and excitatory presynaptic neurons, amacrine and bipolar cells, respectively. We find that restoration of light sensitivity in retinal neurons leads to restoration of the pupillary reflex.

Conclusions: : AAQ bestows light sensitivity onto multiple cell types, including amacrine, bipolar, and ganglion cells; consequently inducing light-evoked spiking activity in ganglion cells in blind retinas from rd1 mice. These results show that AAQ is a tool that restores visual sensitivity in retinal degenerative animal models and has the potential for future clinical applications.

Keywords: retina • degenerations/dystrophies 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.